Real-world efficacy and problems of once-daily use of inhaled steroid (fluticasone furoate) combined with long-acting beta-2 agonist (vilanterol) in Japanese patients with asthma-Reference-Cited by-同舟云学术

Real-world efficacy and problems of once-daily use of inhaled steroid (fluticasone furoate) combined with long-acting beta-2 agonist (vilanterol) in Japanese patients with asthma

Published:2019-01-01 Issue:1 Volume:6 Page:1600632
ISSN:2331-205X
Container-title:Cogent Medicine
language:en
Short-container-title:Cogent Medicine

Author:

Umeda Akira¹,Yamane Tateki¹,Mochizuki Taichi¹²,Inoue Yasushi¹²,Tsushima Kenji¹³,Miyagawa Kazuya⁴,Mochida Atsumi⁴,Takeda Hiroshi⁴,Okada Yasumasa⁵,Fukunaga Koich⁶

Affiliation:

1. Department of Internal Medicine, International University of Health and Welfare (IUHW) Shioya Hospital, Yaita, Japan

2. Respiratory Diseases Center, IUHW Mita Hospital, Tokyo, Japan

3. Department of Pulmonary Medicine, School of Medicine, IUHW, Narita, Japan

4. Department of Pharmacology, School of Pharmacy, IUHW, Otawara, Japan

5. Department of Internal Medicine, National Hospital Organization Murayama Medical Center, Musashimurayama, Japan

6. Department of Respiratory Medicine, School of Medicine, Keio University, Tokyo, Japan

Publisher

Informa UK Limited

Subject

Applied Psychology,General Biochemistry, Genetics and Molecular Biology

Link